CMC Invest sees AUD 6.08 target for Regis Healthcare stock

Published on 10/13/2026 at 06:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Six ratings imply an AUD 6.08 target for Regis Healthcare stock. REG.AX was AUD 4.42 on October 13, 2026, below target.

Key points in brief

CMC Invest cited an average AUD 6.08 target from six analyst ratings for Regis Healthcare.
Regis reported FY2026 service revenue of AUD 1.35 billion, up 16 percent year over year.
Underlying EBITDA rose 10 percent to AUD 138 million in FY2026.
Regis Healthcare stock was last at AUD 4.42 on October 13, 2026, while market capitalization stood at AUD 1.3 billion.

Regis Healthcare, AU000000REG6, Illustration mit AI erstellt.

Regis Healthcare (ISIN AU000000REG6) has an average AUD 6.08 target from six recent analyst ratings, implying 37.56 percent upside from the AUD 4.42 ASX price on October 13, 2026. Motley Fool reported the target on October 12, 2026, citing CMC Invest and six ratings.

Funding growth meets cost pressure

The immediate issue is the gap between government funding and operating costs. The Australian national aged care classification starting price increased 2.55 percent from AUD 295.64 to AUD 303.19 on October 1, 2026, while Regis has described the funding setting as below prevailing cost inflation, according to Motley Fool.

That pressure makes the FY2026 operating figures important. Regis reported service revenue of AUD 1.35 billion, up 16 percent, while underlying EBITDA increased 10 percent to AUD 138 million and operating cash flow rose 10 percent to AUD 336 million, according to the company earnings call transcript published by Yahoo Finance on September 15, 2026.

What did FY2026 deliver?

The earnings mix was broader than revenue growth alone. Mature home occupancy reached 96 percent from 95.60 percent, occupied bed days increased 8 percent to 2.85 million, and net RAD cash inflows rose 28 percent to more than AUD 250 million in FY2026, the same transcript reported.

Regis also ended FY2026 with net cash of AUD 174 million and resolved a final dividend of AUD 0.094 per share, up 16 percent from the previous year. The balance sheet therefore provides a measurable counterweight to the funding concern, although the 2.55 percent starting-price increase remains below the cost pressure described in the September coverage.

Targets and next reporting date

RBC Capital maintained a Hold rating and set a separate AUD 5.00 target on September 15, 2026, according to TipRanks. That target sits below the AUD 6.08 average cited by CMC Invest, showing a wider range of views even as both figures remain above the October 13 price.

TradingView lists February 23, 2027 as the next expected earnings date for Regis Healthcare, while the latest completed reporting period is FY2026, according to TradingView.

Stock remains below its yearly high

Regis Healthcare was last at AUD 4.42 on the ASX on October 13, 2026 at 3:03 p.m. AEDT. Its market capitalization was AUD 1.3 billion, and the 52-week range was AUD 3.85 to AUD 8.20 on the same date. The further course of trading is shown by the continuously updated real-time quote of Regis Healthcare stock.